Synthesis and characterization of coprecipitation-derived ferrimagnetic glass-ceramic
- 293 Downloads
Ferrimagnetic glass-ceramics could be used for magnetic induction hyperthermia. This technique is utilised for the destruction of solid neoplastic diseases by application of an alternating magnetic field. Biocompatible ferrimagnetic materials could be easily incorporated into a tumour and could generate heat mainly by hysteresis loss.
A ferrimagnetic glass-ceramic in the system SiO2–Na2O–CaO–P2O5–FeO–Fe2O3 has been prepared by melting of the coprecipitation-derived raw materials. This glass-ceramic contains a unique crystalline phase, magnetite, embedded in an amorphous matrix. Magnetite crystals precipitate during cooling from melting temperature. This glass-ceramic would no longer require any nucleation and growth thermal treatment, since the maximal quantity of magnetite crystals was produced during cooling. The average unit-cell parameter, crystallite size of magnetite, and the quantitative ratio of the crystallographic phases in the glass-ceramic samples were evaluated using two different methods. Similar results were obtained with both methods. The magnetite crystals are about 50 nm in dimensions. The samples contain 45 wt% of magnetite, homogeneously distributed in the amorphous residual matrix.
The as prepared glass-ceramic has a saturation magnetisation of 34 A·m2/kg and a coercive force of 6.7 kA/m. The estimated magnetic loss/cycle under the magnetic field up to 796 kA/m is around 1.45 mJ/g. The specific power loss of this glass-ceramic under a magnetic field of 40 kA/m and a frequency of 440 kHz is 25 W/g.
This material showed a bioactive behaviour, as after 2 weeks of soaking in a simulated body fluid the formation of a hydroxylapatite layer on their surface was observed. This feature makes it also suitable for bone cancer.
KeywordsMagnetite Na2O Simulated Body Fluid Coercive Force Amorphous Matrix
Unable to display preview. Download preview PDF.
- 1.G. H. NUSSBAUM, “Physical Aspects of Hyperthermia” (American Institute of Physics, Inc., 1982).Google Scholar
- 2.B. N. GRAY and S. K. JONES, “Targeted Hysteresis hyperthermia as a method for treating diseased tissue”, U. S. Patent 6167313 (2000).Google Scholar
- 4.BORRELLI et al., “Radio frequency induced hyperthermia for tumor therapy”, U.S. Patent 4323056 (1982).Google Scholar
- 10.M. FERRARIS, O. BRETCANU and E. VERNÉ, “Biocompatible magnetic materials for hyperthermia cancer treatment and their synthesis processing”, Italian Patent IT2002TO00994 (2002).Google Scholar
- 11.O. BRETCANU, Ph.D thesis: “Magnetic Biomaterials for Hyperthermic Treatment of Cancer” (Politecnico di Torino, Italy, 2004).Google Scholar
- 12.H. KLUG and L. ALEXANDER, “X-ray Diffraction Procedures for Polycrystalline and Amorphous Materials” (John Wiley & Sons, Inc., London, 1962).Google Scholar
- 13.R. A. YOUNG, “The Rietveld Method” (IUCr, Oxford University Press, Oxford, UK, 1993).Google Scholar
- 18.T. KOKUBO, Protocol for preparing Simulated Body Fluid SBF, http://sung7.kuic.kyoto-u.ac.jp/others/SBF/SBF_E.htmlGoogle Scholar
- 20.O. BRETCANU, E. VERNÉ, L. BORELLO and A. R. BOCCACCINI, “Bioactivity of degradable polymer sutures coated with bioactive glass”, J. Mater. Sci.: Mater. Med. 15 (2004) 893.Google Scholar
- 21.R. D. CULLITY, “Introduction to Magnetic Materials” (Addison-Wesley Publishing Company Inc., 1972).Google Scholar
- 22.F. FIORILLO, Introduzione ai materiali magnetici, Istituto Elettrotecnico Nazionale Galileo Ferrarsi, Torino, 2001.Google Scholar
- 23.E. GENOVA and A. GOBETTO, Appunti di ferromagnetismo: perdite nei materiali ferromagnetici, Istituto Elettrotecnico Nazionale Galileo Ferraris, Torino, 1984Google Scholar